These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33051990)

  • 61. Comparison of cytomegalovirus pp-65 antigenemia assay and plasma DNA correlation with the clinical outcome in transplant recipients.
    de Oña M; Melón S; Galarraga MC; Palacio A; Lambert JL; Bernardo MJ; Rodríguez M; Gómez E
    Transpl Int; 2005 Jan; 18(1):43-6. PubMed ID: 15612982
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Evaluation of cytomegalovirus quantification in blood by the R-gene real-time PCR test].
    Marque-Juillet S; Touzard A; Monnier S; Fernand-Laurent C; Therby A; Rigaudeau S; Harzic M
    Pathol Biol (Paris); 2010 Apr; 58(2):162-5. PubMed ID: 19854587
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Monitoring cytomegalovirus infection in adult and pediatric bone marrow transplant recipients by a real-time PCR assay performed with blood plasma.
    Leruez-Ville M; Ouachée M; Delarue R; Sauget AS; Blanche S; Buzyn A; Rouzioux C
    J Clin Microbiol; 2003 May; 41(5):2040-6. PubMed ID: 12734246
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cytomegalovirus and ulcerative colitis: Place of antiviral therapy.
    Pillet S; Pozzetto B; Roblin X
    World J Gastroenterol; 2016 Feb; 22(6):2030-45. PubMed ID: 26877608
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Impact of Cytomegalovirus Infection on Severe Hepatitis C Recurrence in Patients Undergoing Liver Transplantation.
    Caston JJ; Castells L; Varo E; Gomez MA; de la Mata M; Campos-Varela I; Lumbreras C; Gonzalez-Dieguez L; Fabregat J; Herrero I; Salcedo M; Sanchez-Antolín G; Torre-Cisneros J
    Transplantation; 2016 Mar; 100(3):593-9. PubMed ID: 26371595
    [TBL] [Abstract][Full Text] [Related]  

  • 66. CMV-antigenemia in peripheral blood for the diagnosis of CMV disease in HIV-infected patients.
    Salzberger B; Franzen C; Fätkenheuer G; Cornely O; Schwenk A; Rasokat H; Diehl V; Schrappe M
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Apr; 11(4):365-9. PubMed ID: 8601222
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Reactivation of cytomegalovirus predicts poor prognosis in patients on intensive immunosuppressive treatment for collagen-vascular diseases.
    Hanaoka R; Kurasawa K; Maezawa R; Kumano K; Arai S; Fukuda T
    Mod Rheumatol; 2012 Jun; 22(3):438-45. PubMed ID: 21915676
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effects of changing immunosuppressive regimen on the incidence, duration, and viral load of cytomegalovirus infection in renal transplantation: a single center report.
    de Maar EF; Verschuuren EA; Homan vd Heide JJ; Kas-Deelen DM; Jagernath D; The TH; Ploeg RJ; van Son WJ
    Transpl Infect Dis; 2002 Mar; 4(1):17-24. PubMed ID: 12123422
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparison between antigenemia and a quantitative-competitive polymerase chain reaction for the diagnosis of cytomegalovirus infection after heart transplantation.
    Camargo LF; Uip DE; Simpson AA; Caballero O; Stolf NA; Vilas-Boas LS; Pannuti CS
    Transplantation; 2001 Feb; 71(3):412-7. PubMed ID: 11233903
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Quantification of cytomegalovirus DNA levels in intestinal biopsies as a diagnostic tool for CMV intestinal disease.
    Ganzenmueller T; Henke-Gendo C; Schlué J; Wedemeyer J; Huebner S; Heim A
    J Clin Virol; 2009 Nov; 46(3):254-8. PubMed ID: 19748823
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Development of cytomegalovirus (CMV) disease may be predicted in HIV-infected patients by CMV polymerase chain reaction and the antigenemia test.
    Dodt KK; Jacobsen PH; Hofmann B; Meyer C; Kolmos HJ; Skinhøj P; Norrild B; Mathiesen L
    AIDS; 1997 Mar; 11(3):F21-8. PubMed ID: 9147416
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Role of the cytomegalovirus (CMV)-antigenemia assay as a predictive and follow-up detection tool for CMV disease in AIDS patients.
    Hoshino Y; Nagata Y; Taguchi H; Masunaga A; Fujino Y; Mochizuki M; Nakamura T; Iwamoto A
    Microbiol Immunol; 1999; 43(10):959-65. PubMed ID: 10585142
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Comparison of two leukocyte extraction methods for cytomegalovirus antigenemia assay.
    García A; Niubò J; Benítez MA; Viqueira M; Pérez JL
    J Clin Microbiol; 1996 Jan; 34(1):182-4. PubMed ID: 8748299
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Diagnostic Accuracy of Blood-Based Tests and Histopathology for Cytomegalovirus Reactivation in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    Tandon P; James P; Cordeiro E; Mallick R; Shukla T; McCurdy JD
    Inflamm Bowel Dis; 2017 Apr; 23(4):551-560. PubMed ID: 28296820
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cytomegalovirus infection after autologous stem cell transplantation: incidence and outcome in a group of patients undergoing a surveillance program.
    Rossini F; Terruzzi E; Cammarota S; Morini F; Fumagalli M; Verga L; Elli E; Verga M; Miccolis I; Parma M; Pogliani EM
    Transpl Infect Dis; 2005; 7(3-4):122-5. PubMed ID: 16390400
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active antiretroviral therapy.
    Salmon-Céron D; Mazeron MC; Chaput S; Boukli N; Senechal B; Houhou N; Katlama C; Matheron S; Fillet AM; Gozlan J; Leport C; Jeantils V; Freymuth F; Costagliola D
    AIDS; 2000 May; 14(8):1041-9. PubMed ID: 10853987
    [TBL] [Abstract][Full Text] [Related]  

  • 77. First experiences with an accelerated CMV antigenemia test: CMV Brite Turbo assay.
    Visser CE; van Zeijl CJ; de Klerk EP; Schillizi BM; Beersma MF; Kroes AC
    J Clin Virol; 2000 Jun; 17(1):65-8. PubMed ID: 10814941
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Differences between the quantitative antigenemia assay and the cobas amplicor monitor quantitative PCR assay for detecting CMV viraemia in bone marrow and solid organ transplant patients.
    Flexman J; Kay I; Fonte R; Herrmann R; Gabbay E; Palladino S
    J Med Virol; 2001 Jul; 64(3):275-82. PubMed ID: 11424115
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Molecular-based strategies for assessment of CMV infection and disease in immunosuppressed transplant recipients.
    Kulkarni A; Westmoreland D; Fox JD
    Clin Microbiol Infect; 2001 Apr; 7(4):179-86. PubMed ID: 11422239
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Factors associated with cytomegalovirus antigenemia in patients with rheumatic disease: A retrospective study.
    Ogata H; Aoki N; Nagano K; Hakamata M; Bamba Y; Shibata S; Koizumi T; Ohshima Y; Watanabe S; Moro H; Koya T; Kikuchi T
    J Infect Chemother; 2022 Nov; 28(11):1471-1477. PubMed ID: 35850402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.